Is ESAB a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for ESAB Corporation (ESAB) rests on Recurring consumables base: A large share of ESAB's revenue comes from welding and cutting consumables that customers reorder continuously, a razor-and-blades dynamic that smooths results versus pure equipment makers. The bear case rests on roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Analysts covering it publish targets from $117.00 to $154.00 against a $85.38 price, so even the professionals disagree by 27% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
ESAB Corporation, founded in 1904 and spun out as a standalone public company in 2022, is one of the three largest welding and cutting businesses in the world alongside Lincoln Electric and Illinois Tool Works. It sells welding and cutting equipment, automation systems, and the electrodes, wires, and cutting consumables used across general industry, construction, infrastructure, transportation, energy, renewables, and medical gas control. The consumables side generates recurring, razor-and-blades style revenue, and roughly 80% of sales come from outside the United States, with about half of revenue from high-growth regions like South America, India, and Asia Pacific. The investment picture is that of an industrial compounder: steady organic growth layered with frequent bolt-on acquisitions (recent deals include EWM, Bavaria Schweisstechnik, and gas-control and medical-gas businesses), all integrated through the proprietary ESAB Business Excellence (EBX) system to expand margins. Revenue reached roughly $2.85 billion in 2025 and Q1 2026 set a record at about $746 million, though core-organic growth has been near flat and integration costs have pressured margins recently. The stock trades as a mid-cap industrial whose returns hinge on emerging-market end demand, currency, and management's ability to keep converting acquisitions into higher margins.
The bull case: what would have to be true for $154.00
The most optimistic published target on ESAB is $154.00, +80.4% from the $85.38 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Recurring consumables base
A large share of ESAB's revenue comes from welding and cutting consumables that customers reorder continuously, a razor-and-blades dynamic that smooths results versus pure equipment makers. This installed base of equipment pulls through repeat consumable sales for years. It gives the business a more stable revenue floor than the cyclical capital-equipment cycle alone would suggest.
2. Bolt-on M&A compounding
ESAB positions itself as an industrial compounder, pairing organic growth with a steady stream of tuck-in acquisitions in welding equipment, consumables, gas control, and medical gas. Deals such as EWM, Bavaria Schweisstechnik, and several gas-control businesses expand its portfolio and geographic reach. Management applies the EBX operating system to integrate these and lift acquired margins over time.
3. Emerging-market and high-growth exposure
About 80% of sales are outside the U.S., and roughly 52% of 2025 revenue came from high-growth regions including South America, India, and Asia Pacific. This tilt gives ESAB structural exposure to industrialization and infrastructure spending in faster-growing economies. It differentiates ESAB from more U.S.-centric welding peers.
4. EBX-driven margin expansion
The ESAB Business Excellence (EBX) system is management's lever for continuous cost and productivity improvement across manufacturing and integrated acquisitions. Core adjusted EBITDA margins have run near 19% to 20%. The stated strategy is to keep expanding margins even when organic sales growth is muted.
The bear case: what would have to be true for $117.00
The most pessimistic published target is $117.00, +37.0% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks ESAB Corporation is worth if the risks below bite instead of the drivers above.
Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Core-organic growth has been near flat recently while integration of acquisitions has pressured margins, so the compounder thesis depends on execution rather than end-market tailwinds. Geopolitical exposure is real: management flags the war in Ukraine and Middle East tensions, and Russian operations were around 5% of 2025 net sales. As an industrial supplier ESAB is cyclical, tied to construction, infrastructure, energy, and general fabrication activity. Legacy asbestos-related liabilities, supply-chain disruption, tariffs, and commodity input costs are additional overhangs disclosed in its filings.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ESAB already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on ESAB
10 analysts cover ESAB, with an average target of $135.40 (+58.6% against $85.38) and a split of 10 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ESAB forecast and price target page.
How is ESAB valued? (as of JULY 2026)
Snapshot for ESAB as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$2.85B
- Q1 2026 sales: ~$746M (+10% reported)
- Core adj. EBITDA margin: ~19%
- 2026 sales guidance: ~$2.85B to $2.95B
- Market cap: ~$7.5B
- Q1 2026 core adj. EPS: ~$1.31
ESAB reported record Q1 2026 sales of about $746 million, up 10% on a reported basis but down roughly 1% on a core-organic basis, with core adjusted EPS of about $1.31. Management guided full-year 2026 sales to roughly $2.85 to $2.95 billion (about 6% to 9% total growth, 2% to 4% organic). With a market cap near $7.5 billion the stock carries a mid-to-high-20s earnings multiple typical of a quality industrial compounder.
How do you decide if ESAB is a buy?
Rather than asking whether ESAB is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ESAB indirectly through an index or sector ETF before adding more.
What would change your mind on ESAB
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Recurring consumables base stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the ESAB stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ESAB against your real portfolio and see your actual exposure before deciding.
Investing in ESAB Corporation with AI
Connect the broker you already use and ask Walnut's AI how ESAB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is ESAB a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Recurring consumables base, with revenue (ttm) at ~$2.85B. The bear case rests on roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Analysts covering it are spread from $117.00 to $154.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell ESAB?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $117.00, +37.0% from the $85.38 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for ESAB?
+
Recurring consumables base. A large share of ESAB's revenue comes from welding and cutting consumables that customers reorder continuously, a razor-and-blades dynamic that smooths results versus pure equipment makers. The most optimistic analyst target on ESAB is $154.00, +80.4% from the $85.38 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for ESAB?
+
Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Core-organic growth has been near flat recently while integration of acquisitions has pressured margins, so the compounder thesis depends on execution rather than end-market tailwinds. Geopolitical exposure is real: management flags the war in Ukraine and Middle East tensions, and Russian operations were around 5% of 2025 net sales. As an industrial supplier ESAB is cyclical, tied to construction, infrastructure, energy, and general fabrication activity. Legacy asbestos-related liabilities, supply-chain disruption, tariffs, and commodity input costs are additional overhangs disclosed in its filings. The most pessimistic published target is $117.00, +37.0% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does ESAB Corporation do?
+
ESAB Corporation, founded in 1904 and spun out as a standalone public company in 2022, is one of the three largest welding and cutting businesses in the world alongside Lincoln Ele
What would have to change for ESAB to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Recurring consumables base) stalling in the reported numbers rather than in the narrative, the risk above (roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does ESAB Corporation do?
+
ESAB makes welding and cutting equipment, automation systems, and the consumables (electrodes, wires, cutting tips) used to run them. It also has a gas-control and medical-gas business. Customers span construction, infrastructure, energy, transportation, shipbuilding, and general fabrication.
Is ESAB a US-listed stock?
+
Yes. ESAB Corporation trades on the New York Stock Exchange under the ticker ESAB. It was spun off from Colfax (later Enovis) as a standalone public company in 2022. Note that Esab India is a separate listing on Indian exchanges.
How does ESAB make money?
+
ESAB sells welding and cutting equipment, then earns recurring revenue from the consumables customers reorder to keep using that equipment, a razor-and-blades model. Consumables provide a stable revenue base while equipment and automation drive newer growth.
Walnut is informational, not investment advice, and gives no verdict on ESAB. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.